[1]
Sari, S.P. et al. 2018. COST-EFFECTIVENESS ANALYSIS OF CEFTRIAXONE GENERIC AND PATENT IN CHILDREN WITH TYPHOID. International Journal of Applied Pharmaceutics. 10, 1 (Dec. 2018), 76–80. DOI:https://doi.org/10.22159/ijap.2018.v10s1.16.